ImmunoSens (Immunosens Co., Ltd.) is a French/Japanese company that develops, manufactures, and sells point-of-care testing (POCT) devices based on gold nanoparticle electrochemical immunoassay technology. The company's GLEIA technology enables compact, high-sensitivity diagnostic testing for disease biomarkers. It is not a pharmaceutical manufacturer.
POCT diagnostic devices, gold nanoparticle immunoassay, electrochemical detection, biomarker testing
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.